The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection
Nature Reviews Microbiology2013Vol. 11(7), pp. 482–496
Citations Over TimeTop 1% of 2013 papers
Related Papers
- → Cyclophilin and NS5A Inhibitors, but Not Other Anti-Hepatitis C Virus (HCV) Agents, Preclude HCV-Mediated Formation of Double-Membrane-Vesicle Viral Factories(2015)56 cited
- → Modulation of Cell Death Pathways by Hepatitis C Virus Proteins in Huh7.5 Hepatoma Cells(2017)14 cited
- → Nonstructural Protein 5A (NS5A) and Human Replication Protein A Increase the Processivity of Hepatitis C Virus NS5B Polymerase Activity In Vitro(2014)10 cited
- → Hepatitis C Virus—Progress Toward Inhibiting the Nonenzymatic Viral Proteins(2011)4 cited
- → Functional interactions of structural and NS proteins of hepatitis c virus(2017)